Phase 4 Crohn's Disease and Colitis Trial, Not Yet Recruiting NCT07059130 Sponsor: Rubix LS Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Phase 4 Crohn's Disease and Colitis Trial, Not Yet Recruiting

NCT07059130
Not Yet Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 60 years of age or older at the time of joining the trial
  • You have been diagnosed with moderate-to-severe Crohn's Disease or moderate-to-severe Ulcerative Colitis, confirmed by specific medical scoring tools (confirm with trial site)
  • You are able to understand the study and give your own consent to participate

Who may not be able to join:

  • You have had major bowel or digestive surgery in the last 3 months
  • You currently have an active infection that requires antibiotic or antiviral medication
  • You currently have cancer, or have had cancer in the past 5 years (an exception may apply if you had a fully treated type of skin cancer with no spread for at least 3 years — confirm with trial site)
  • You are currently taking part in, or have taken part in, another clinical trial involving an experimental treatment within the last 30 days
  • You have a known allergy or medical reason preventing you from taking a specific biologic medication called Mirikizumab
  • You have had unstable chest pain, a heart attack, or a heart procedure in the past 6 months
  • You have high blood pressure that remains too high even with treatment (confirm with trial site)
  • You have been diagnosed with moderate-to-severe heart failure
  • You have a significant irregular heartbeat or other unstable heart condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Sponsor
Rubix LS
Registry
ClinicalTrials.gov
Start date
16 July 2025
Est. completion
1 January 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinical Remission at Week 24

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov